Abstract
Trace elements might be associated with the development of hepatocellular carcinoma (HCC) and the efficacy of chemotherapy against HCC. Therefore, this study aimed to explore the association between trace elements and efficacy of chemotherapy in patients with HCC. Cancer, cancer-adjacent, and cancer-free tissues were collected intraoperatively from 55 patients with HCC between January 2001 and April 2004 at the Affiliated Tumor Hospital of Guangxi Medical University in Guangxi (China), a high HCC incidence area in the world. Trace element levels were analyzed by atomic absorption spectrophotometry. In vitro sensitivity of cancer cells to five chemotherapeutic drugs (5-fluorouracil, doxorubicin, cisplatin, carboplatin, and mitomycin) was tested using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay in cancer cells from 32 patients. Zinc, copper, manganese, and selenium levels had the same gradient distribution in different liver tissues: cancer < cancer-adjacent < cancer-free tissues. Copper levels of cancer tissues were negatively correlated with body weight (r = −0.278, P = 0.027), while manganese and selenium levels were negatively correlated with age (r = −0.297, P = 0.015; r = −0.285, P = 0.018, respectively). Simple correlation analyses revealed that the carboplatin sensitivity was negatively correlated with selenium levels of cancer tissues, while doxorubicin sensitivity was negatively correlated with manganese levels (r = −0.497, P = 0.004). Partial correlation analyses showed that doxorubicin sensitivity only was negatively correlated with manganese levels (r = −0.450, P = 0.014). These results suggest that the selenium and manganese content in primary HCC tissues could influence the response of the HCC cells to carboplatin and doxorubicin. These preliminary results provide a basis for future studies.
Similar content being viewed by others
References
Kohler BA, Ward E, McCarthy BJ, Schymura MJ, Ries LA, Eheman C, Jemal A, Anderson RN, Ajani UA, Edwards BK (2011) Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 103(9):714–736. doi:10.1093/jnci/djr077
Centers for Disease Control Prevention (2010) Hepatocellular carcinoma—United States, 2001-2006. MMWR Morb Mortal Wkly Rep 59(17):517–520
Altekruse SF, McGlynn KA, Reichman ME (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27(9):1485–1491. doi:10.1200/JCO.2008.20.7753
Zhang CY, Huang TR, Yu JH, Zhang ZQ, Li JL, Deng W, Ye SY, Zhou DN, He ZF (2010) Epidemiological analysis of primary liver cancer in the early 21st century in Guangxi province of China. Chin J Cancer 29(5):545–550
Van Rensburg SJ, Cook-Mozaffari P, Van Schalkwyk DJ, Van der Watt JJ, Vincent TJ, Purchase IF (1985) Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br J Cancer 51(5):713–726
Devita VT Jr, Lawrence TS, Rosenberg SA (eds) (2011) Cancer of the liver. In: Cancer Principles & Practice of Oncology. Philadelphia, Lippincott Williams & Wilkins, USA, pp 997–1001
Cheng WH (2009) Impact of inorganic nutrients on maintenance of genomic stability. Environ Mol Mutagen 50(5):349–360. doi:10.1002/em.20489
Tashiro H, Kawamoto T, Okubo T, Koide O (2003) Variation in the distribution of trace elements in hepatoma. Biol Trace Elem Res 95(1):49–63. doi:10.1385/BTER:95:1:49
Maeda T, Shimada M, Harimoto N, Tsujita E, Maehara S, Rikimaru T, Tanaka S, Shirabe K, Maehara Y (2005) Role of tissue trace elements in liver cancers and non-cancerous liver parenchyma. Hepato-Gastroenterology 52(61):187–190
Jin J, Hao. S, Yu HX, Yao HY, Mao J, Wang CJ, Yang MJ, Mi Y (2007) Evaluation of Cu in hepatocellular carcinoma by particle induced X-ray emission. J Trace Elem Med Biol 21(4):255–260. doi:10.1016/j.jtemb.2007.06.004
Balter V, Nogueira da Costa A, Bondanese VP, et al. (2015) Natural variations of copper and sulfur stable isotopes in blood of hepatocellular carcinoma patients. Proc Natl Acad Sci U S A 112(4):982–985. doi:10.1073/pnas.1415151112
Bruix J, Sherman M, American Association for the Study of Liver D (2011) Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022. doi:10.1002/hep.24199
Lopez PM, Villanueva A, Llovet JM (2006) Systematic review: evidence-based management of hepatocellular carcinoma—an updated analysis of randomized controlled trials. Aliment Pharmacol Ther 23(11):1535–1547. doi:10.1111/j.1365-2036.2006.02932.x
Tobey RA, Tesmer JG (1985) Differential response of cultured human normal and tumor cells to trace element-induced resistance to the alkylating agent melphalan. Cancer Res 45(6):2567–2571
Ivanova D, Bakalova R, Lazarova D, Gadjeva V, Zhelev Z (2013) The impact of reactive oxygen species on anticancer therapeutic strategies. Adv Clin Exp Med 22(6):899–908
Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417(1):1–13. doi:10.1042/BJ20081386
Chinese Society of Liver Cancer (2000) The diagnostic criteria of primary liver cancer. Chin J Hepatol 8:135
Tang D, Wei C (1995) MTT assay as a method of determining the chemosensitivity in human primary hepatocellular carcinoma. Pract J Cancer 10:14–15
Sargent JM, Taylor CG (1989) Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia. Br J Cancer 60(2):206–210
Elmberg M, Hultcrantz R, Ekbom A, et al. (2003) Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology 125(6):1733–1741
Kumagi T, Horiike N, Michitaka K, et al. (2004) Recent clinical features of Wilson’s disease with hepatic presentation. J Gastroenterol 39(12):1165–1169. doi:10.1007/s00535-004-1466-y
Wang YX, Qin JF, Wu SM, Yan LB (1990) Study on the relation of Se, Mn, Fe, Sr, Pb, Zn, Cu, and Ca to liver cancer mortality from analysis of scalp hair. Sci Total Environ 91:191–198
Bjelakovic G, Nikolova D, Simonetti RG, Gluud C (2004) Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 364(9441):1219–1228. doi:10.1016/S0140-6736(04)17138-9
Liaw KY, Lee PH, Wu FC, Tsai JS, Lin-Shiau SY (1997) Zinc, copper, and superoxide dismutase in hepatocellular carcinoma. Am J Gastroenterol 92(12):2260–2263
Yang CS (2000) Vitamin nutrition and gastroesophageal cancer. J Nutr 130(2S Suppl):338S–339S
Lu H, Cai L, Mu LN, et al. (2006) Dietary mineral and trace element intake and squamous cell carcinoma of the esophagus in a Chinese population. Nutr Cancer 55(1):63–70. doi:10.1207/s15327914nc5501_8
Yu MW, Horng IS, Hsu KH, Chiang YC, Liaw YF, Chen CJ (1999) Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. Am J Epidemiol 150(4):367–374
Geybels MS, Verhage BA, van Schooten FJ, van den Brandt PA (2012) Measures of combined antioxidant and pro-oxidant exposures and risk of overall and advanced stage prostate cancer. Ann Epidemiol 22(11):814–820. doi:10.1016/j.annepidem.2012.07.010
Kristal AR, Darke AK, Morris JS, et al. (2014) Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk. J Natl Cancer Inst 106(3):djt456. doi:10.1093/jnci/djt456
Kenfield SA, Van Blarigan EL, DuPre N, Stampfer MJ, Giovannucci EL, Chan JM (2015) Selenium supplementation and prostate cancer mortality. J Natl Cancer Inst 107(1):360. doi:10.1093/jnci/dju360
Calvo FB, Santos Junior D, Rodrigues CJ, Krug FJ, Marumo JT, Schor N, Bellini MH (2009) Variation in the distribution of trace elements in renal cell carcinoma. Biol Trace Elem Res 130(2):107–113. doi:10.1007/s12011-009-8325-x
Leung TW, Patt YZ, Lau WY, et al. (1999) Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin Cancer Res 5(7):1676–1681
Yeo W, Mok TS, Zee B, et al. (2005) A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma. J Natl Cancer Inst 97(20):1532–1538. doi:10.1093/jnci/dji315
Su Y (2014) Cancer chemosensitivity testing: review. J Cancer Ther 5:672–679
Burstein HJ, Mangu PB, Somerfield MR, Schrag D, Samson D, Holt L, Zelman D, Ajani JA, American Society of Clinical O (2011) American Society of Clinical Oncology clinical practice guideline update on the use of chemotherapy sensitivity and resistance assays. J Clin Oncol 29(24):3328–3330. doi:10.1200/JCO.2011.36.0354
Ortega R, Moretto P, Fajac A, Benard J, Llabador Y, Simonoff M (1996) Quantitative mapping of platinum and essential trace metal in cisplatin resistant and sensitive human ovarian adenocarcinoma cells. Cell Mol Biol (Noisy-Le-Grand) 42(1):77–88
Raso E, Paku S, Kopper L, Timar J (2003) Trace elements improve survival of DTIC-treated mice with overt liver metastases of Lewis lung carcinoma. Pathol Oncol Res 9(2):96–99
Yu SY, Zhu YJ, Li WG (1997) Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong. Biol Trace Elem Res 56(1):117–124
Yu SY, Zhu YJ, Li WG, Huang QS, Huang CZ, Zhang QN, Hou C (1991) A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol Trace Elem Res 29(3):289–294
Meplan C, Hesketh J (2012) The influence of selenium and selenoprotein gene variants on colorectal cancer risk. Mutagenesis 27(2):177–186. doi:10.1093/mutage/ger058
Brodska B, Holoubek A (2011) Generation of reactive oxygen species during apoptosis induced by DNA-damaging agents and/or histone deacetylase inhibitors. Oxidative Med Cell Longev 2011:253529. doi:10.1155/2011/253529
Acknowledgments
The authors acknowledge the help of the technicians of the pathology department of The Affiliated Tumor Hospital of Guangxi Medical University. The authors thank the patients for their invaluable participation. This study was funded by the Guangxi Natural Science Fund (No. 2010GXNSFA 013243001).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All procedures performed in studies involving human participants were in accordance with the ethical standards of the hospital Ethics Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Conflict of Interest
The authors declare that they have no competing interests.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Liu, Z., Yang, W., Long, G. et al. Trace Elements and Chemotherapy Sensitivity. Biol Trace Elem Res 173, 283–290 (2016). https://doi.org/10.1007/s12011-016-0667-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-016-0667-6